• Return to Headlines

Zogenix Inc: The Winning Streak Continues (ZGNX)

By Shiri Gupta

Zogenix Inc (NASDAQ:ZGNX) traded today at a new 52-week high of $58.30. So far today approximately 3.4 million shares have been exchanged, as compared to an average 30-day volume of 540,000 shares.

Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.

In the past 52 weeks, shares of Zogenix Inc have traded between a low of $7.33 and a high of $58.30 and are now at $55.50, which is 657% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 0.9%.

Zogenix Inc (NASDAQ:ZGNX) defies analysts with a current price ($55.50) 2.7% above its average consensus price target of $54.00. The stock should discover initial support at its 50-day moving average (MA) of $42.56 and subsequent support at its 200-day MA of $39.41.

SmarTrend is tracking the current trend status for Zogenix Inc and will alert subscribers who have ZGNX in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows zogenix inc

Ticker(s): ZGNX